SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-038656
Filing Date
2020-08-10
Accepted
2020-08-10 08:42:53
Documents
57
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tptx-10q_20200630.htm 10-Q 2119229
2 EX-10.1 tptx-ex101_172.htm EX-10.1 20082
3 EX-10.2 tptx-ex102_175.htm EX-10.2 46552
4 EX-10.3 tptx-ex103_174.htm EX-10.3 75876
5 EX-10.4 tptx-ex104_300.htm EX-10.4 643624
6 EX-31.1 tptx-ex311_6.htm EX-31.1 19371
7 EX-31.2 tptx-ex312_9.htm EX-31.2 19325
8 EX-32.1 tptx-ex321_8.htm EX-32.1 10164
9 EX-32.2 tptx-ex322_7.htm EX-32.2 10175
  Complete submission text file 0001564590-20-038656.txt   6615447

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT tptx-20200630.xml EX-101.INS 1095919
11 XBRL TAXONOMY EXTENSION SCHEMA tptx-20200630.xsd EX-101.SCH 33967
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tptx-20200630_cal.xml EX-101.CAL 37698
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tptx-20200630_def.xml EX-101.DEF 103568
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE tptx-20200630_lab.xml EX-101.LAB 307364
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tptx-20200630_pre.xml EX-101.PRE 225694
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Filer) CIK: 0001595893 (see all company filings)

IRS No.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38871 | Film No.: 201087289
SIC: 2834 Pharmaceutical Preparations